seksual problems after cancer treatment Sexual health sexuality
Conditions
Interventions
None listed
Sponsors
Medical University Graz
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: The study sample will be composed of a consecutive series of cancer patients who meet the study eligibility criteria in each participating centre. Study participants will be enrolled in four groups: Group A: Patients undergoing surgery alone Group B: Patients who receive chemotherapy and/or radiotherapy and/or endocrine therapies as first line treatment with curative intention Group C: Patients who receive palliative treatment (any treatment) Group D: Patients with no evidence of disease who have completed treatment for at least 6 months up to 5 years (test-retest) The SHQ-C22 will be used in patients from across all cancer sites and stages. Sampling will be on the basis of gender, age, primary cancer diagnosis and treatment. Inclusion criteria: a) Histological confirmed diagnosis of cancer (primary, recurrent or metastatic disease) b) Any tumour site and stage c) Mentally fit to complete the questionnaires d) Able to understand the language of the questionnaires e) 18 years of age or above f) Patient is willing to give informed written consent
Exclusion criteria
Exclusion criteria: Patients participating in other QoL studies that might interfere with this study b) Patients who are unable to self-complete the questionnaires
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint of the study is to confirm the hypothesized scale structure of the EORTC SHQ-C22. | — |
Secondary
| Measure | Time frame |
|---|---|
| Scale Structure, Reliability, Convergent validity, Known-group comparisons, Responsiveness to change analysis | — |
Countries
Netherlands
Outcome results
None listed